Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

96
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent treatment outcomes of cervical intraepithelial neoplasia in south western Uganda: a six year retrospective study.

Gynecologic oncology reports·2026
Same author

Impact of Patient-Oncologist Language Concordance on the Quality of End-of-Life Care.

Journal of palliative medicine·2026
Same author

The likely possibility of predicting treatment outcomes of cervical lesions using serum FOXP3 and P16INK4A as shown by a cohort study in South Western Uganda.

Discover oncology·2026
Same author

The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

The effects of government-led cash transfer programmes on behavioural and health determinants of mortality: a difference-in-differences study.

Lancet (London, England)·2025
Same author

Money, Medicine, and Motherhood: Developing a Cash Transfer for Pregnant Women with HIV in Rural Haiti.

AIDS and behavior·2025

Related Experiment Video

Updated: Jul 21, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.3K

Vulvar leiomyosarcoma: A case report.

Bernard Gilles1, Christophe Millien1, Giovanni A Bordes1

  • 1Department of Obstetrics & Gynecology, Mirebalais Teaching Hospital, Mirebalais, Centre, Haiti.

Gynecologic Oncology Reports
|July 28, 2023
PubMed
Summary
This summary is machine-generated.

Vulvar leiomyosarcoma, a rare smooth muscle tumor, can be misdiagnosed as benign. This case highlights challenges in diagnosing and treating this vulvar cancer, impacting patient care.

Keywords:
SarcomaVulvar cancerVulvar leiomyosarcomaVulvar mass

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K

Related Experiment Videos

Last Updated: Jul 21, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.3K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology
  • Oncology

Background:

  • Vulvar leiomyosarcoma is a rare malignancy, representing the most common vulvar sarcoma.
  • This tumor can present with symptoms mimicking benign conditions, potentially leading to delayed diagnosis and treatment.
  • Early and accurate diagnosis is crucial for effective management of vulvar cancers.

Purpose of the Study:

  • To report a case of vulvar leiomyosarcoma in a 35-year-old woman.
  • To illustrate the diagnostic challenges associated with vulvar leiomyosarcoma.
  • To highlight the difficulties in providing safe cancer care in resource-limited settings.

Main Methods:

  • Clinical presentation of a right vulvar mass in a 35-year-old female patient.
  • Surgical excision of the vulvar mass.
  • Histopathological examination and immunohistochemistry for definitive diagnosis.

Main Results:

  • Histopathology and immunohistochemistry confirmed the diagnosis of leiomyosarcoma.
  • The case underscores the potential for misdiagnosis due to the tumor's resemblance to benign masses.
  • Contextual challenges in the healthcare setting impacted the delivery of care.

Conclusions:

  • Vulvar leiomyosarcoma requires high clinical suspicion for timely diagnosis.
  • Accurate histopathological and immunohistochemical analysis is essential for differentiating leiomyosarcoma from benign mimics.
  • Addressing healthcare system challenges is vital for improving cancer care delivery, particularly in resource-limited environments.